-
Company profile
-
Strategy and management
-
Letter from Karl-Ludwig Kley
-
Values and external initiatives
-
Human rights
-
Responsible care
-
-
CR strategy and organization
-
Compliance
-
Guidelines and management systems
-
Stakeholder dialogue
-
-
Products
-
Sustainable products
-
Access to health
-
Our approach
-
Philanthropy and product donations
-
Pricing, production and distribution
-
R&D and partnerships
-
Intellectual property
-
Diagnostics
-
Clinical trials
-
Responsible marketing
-
-
Product safety
-
Safety of drugs
-
Safety of chemical products
-
-
Nanotechnology
-
Genetic engineering
-
Product-related crime
-
Bioethics
-
Clinical trials
-
Animal testing
-
Responsible marketing
-
Interactions with the health care industry
-
Packaging
-
Storage and transport
-
Reuse and recycling
-
-
Suppliers
-
Employees
-
Management
-
Fit for 2018
-
Recruitment and Development
-
Occupational health and safety
-
Diversity and inclusion
-
Work-life balance
-
Dialogue and Co-determination
-
-
Environment
-
Management
-
Climate protection
-
Resource consumption
-
Water protection
-
Waste management
-
Process and plant safety
-
Biodiversity
-
-
Society
-
Management
-
Global projects
-
Praziquantel
-
Minilab
-
Deutsche Philharmonie Merck
-
-
Local responsibility
-
-
Facts and figures
-
Report profile
-
Indicators
-
Economics
-
Compliance
-
Employees
-
Environment
-
Society
-
-
Goals
-
Awards and recognition
-
GRI index
-
Company and Report Profile
-
Economic Performance Indicators
-
Environmental Performance Indicators
-
Social Performance Indicators
-
-
Global Compact COP
-
Assurance report
-
Sitemap
-
Company profile
-
Strategy and management
-
Products
-
Suppliers
-
Employees
-
Environment
-
Society
-
Facts and figures
